Midlife mortality in White non-Hispanic male veterans enrolled in Department of Veterans Affairs primary care, 2003-2014 - Liu CF, Hebert P, Wong ES, Nelson K, Maynard C.
BACKGROUND: After years of decline in mortality rates in the United States, there have been increases in mortality rates in White non-Hispanic Americans ages 45-54, due to increases in deaths from suicide, poisoning, and alcoholic liver disease. OB... (Source: SafetyLit)
Source: SafetyLit - February 17, 2020 Category: International Medicine & Public Health Tags: Alcohol and Other Drugs Source Type: news

Vitamin E effective, safe for fatty liver in HIV patients
(McGill University) A type of fatty liver disease that commonly affects patients with HIV can be safely treated with vitamin E, a McGill-led study has found. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 14, 2020 Category: International Medicine & Public Health Source Type: news

Green tea extract combined with exercise reduces fatty liver disease in mice
(Penn State) The combination of green tea extract and exercise reduced the severity of obesity-related fatty liver disease by 75% in mice fed a high-fat diet, according to Penn State researchers, whose recent study may point to a potential health strategy for people. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 14, 2020 Category: International Medicine & Public Health Source Type: news

Rates of Liver Disease High Among World Trade Center Responders
WEDNESDAY, Feb. 12, 2020 -- World Trade Center (WTC) responders have a three times higher rate of liver disease compared with non-WTC responders, according to a study recently published in Clinical Imaging. Xiangmeng Chen, from the Icahn School of... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 12, 2020 Category: Pharmaceuticals Source Type: news

Researchers find test to ID children at higher risk for cystic fibrosis liver disease
(University of Colorado Anschutz Medical Campus) A major multi-center investigation of children with cystic fibrosis has identified a test that allows earlier identification of those at risk for cystic fibrosis liver disease. The study, which includes 11 clinical sites in North America, was led by Michael Narkewicz, MD, professor of pediatrics from the University of Colorado School of Medicine and Children's Hospital Colorado. The findings of the study are published today ahead of print in The Journal of Pediatrics. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 12, 2020 Category: International Medicine & Public Health Source Type: news

Many Patients With NAFLD Should Be Screened for Liver Cancer, Experts Say Many Patients With NAFLD Should Be Screened for Liver Cancer, Experts Say
Screening and surveillance for hepatocellular carcinoma (HCC) is important in many patients with nonalcoholic fatty liver disease (NAFLD), according to an expert panel of the American Gastroenterological Association (AGA).Reuters Health Information (Source: Medscape Pathology Headlines)
Source: Medscape Pathology Headlines - February 11, 2020 Category: Pathology Tags: Gastroenterology News Source Type: news

Natural compound in vegetables helps fight fatty liver disease
(Texas A&M AgriLife Communications) A new study led by Texas A&M AgriLife Research scientists shows how a natural compound found in cruciferous vegetables can also be used to fight fatty liver disease. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 6, 2020 Category: International Medicine & Public Health Source Type: news

Hospital admissions due to alcohol up 6% in a year
Drinking alcohol was the main reason for 358,000 admissions to hospital in 2018/19 Related items fromOnMedica Domestic abuse link to men with alcohol problems Work to begin on alcohol treatment guideline Doctors and midwives welcome clear alcohol advice Send ‘harmful drinkers’ for liver disease scans, GPs urged Twice as many people being admitted to hospital for alcohol abuse (Source: OnMedica Latest News)
Source: OnMedica Latest News - February 6, 2020 Category: UK Health Source Type: news

Liver disease defect identified
(Source: ScienceNOW)
Source: ScienceNOW - February 6, 2020 Category: Science Authors: Ray, L. B. Tags: Cell Biology, Medicine, Diseases twis Source Type: news

Nonalcoholic Liver Disease'an Epidemic of the 21st Century'Nonalcoholic Liver Disease'an Epidemic of the 21st Century '
Can trigger a cascade of reactions, leading to liver cirrhosis, hepatocellular carcinoma, and liver failure, explains an expert.Medscape Medical News (Source: Medscape Internal Medicine Headlines)
Source: Medscape Internal Medicine Headlines - February 5, 2020 Category: Internal Medicine Tags: Diabetes & Endocrinology News Source Type: news

Modifiable Risk Factors and Long-term Outcomes of NAFLD Modifiable Risk Factors and Long-term Outcomes of NAFLD
Cardiovascular disease is a leading cause of mortality in patients with non-alcoholic fatty liver disease. Can modifying CV risk factors and health behaviors improve outcomes?Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 5, 2020 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Fatty Liver Disease Common Among Young Adults in the U.K.
WEDNESDAY, Jan. 29, 2020 -- One in five young adults in the United Kingdom has steatosis and one in 40 has fibrosis around the age of 24 years, according to a study published online Jan. 15 in The Lancet Gastroenterology& Hepatology. Kushala... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 29, 2020 Category: Pharmaceuticals Source Type: news

Quench Bio launches with $50M to treat 'missing link' to inflammatory disease
What do fatty liver disease, asthma and a rare genetic condition called Familial Mediterranean Fever have in common? A newly launched biotech company believes they can all be treated with one approach. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - January 27, 2020 Category: Pharmaceuticals Authors: Allison DeAngelis Source Type: news

Dr. Laura E. Nagy to Deliver 24th Annual Mark Keller Honorary Lecture at the National Institutes of Health
What:The National Institute on Alcohol Abuse and Alcoholism (NIAAA), part of the National Institutes of Health, announces that Laura E. Nagy, Ph.D., will deliver the 24th Annual Mark Keller Honorary Lecture. The title of her presentation is “Inflammation and Cell Death in Alcohol-Associated Liver Disease.”   (Source: NIAAA News)
Source: NIAAA News - January 23, 2020 Category: Addiction Authors: Katherine Source Type: news

Massachusetts Defies U.S. Trend With Binge Drinkers Drinking Less, Study Shows
(CNN) — Adults in the United States who binge drink are consuming even more alcohol per binging episode, according to a new study published Thursday by the US Centers for Disease Control and Prevention. Researchers analyzed data from the Behavioral Risk Factor Surveillance System over a six-year period and discovered that the annual number of binge drinks among adults who reported excessive drinking jumped on average from 472 in 2011 to 529 in 2017. That’s a 12% increase. In 2017, the number of binge drinks per year among adult binge drinkers ranged from 320 per year in Massachusetts to 1,219 in Wyoming. The nu...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - January 18, 2020 Category: Consumer Health News Authors: Health – CBS Boston Tags: Boston News Health Syndicated CBSN Boston Binge Drinking CNN Massachusetts News Source Type: news

Obesity crisis blamed for a rise in fatty liver disease amongst young adults
One in five young people have fatty liver disease (steatosis), with one in 40 having already developed liver scarring (fibrosis), research published today [15 January] has found. The study, published in The Lancet Gastroenterology& Hepatology, is the first to attempt to determine the prevalence of fatty liver disease and fibrosis in young healthy adults in the UK. (Source: University of Bristol news)
Source: University of Bristol news - January 16, 2020 Category: Universities & Medical Training Tags: Health, International, Research; Faculty of Health Sciences, Faculty of Health Sciences, Bristol Medical School, Faculty of Health Sciences, Population Health Sciences, Institutes, Institutes, ALSPAC; Press Release Source Type: news

Obesity could be linked to a rise in fatty liver disease in young adults
One in five young people have fatty liver disease (steatosis), with one in 40 having already developed liver scarring (fibrosis), research published today [15 January] has found. The study, published in The Lancet Gastroenterology& Hepatology, is the first to attempt to determine the prevalence of fatty liver disease and fibrosis in young healthy adults in the UK. (Source: University of Bristol news)
Source: University of Bristol news - January 16, 2020 Category: Universities & Medical Training Tags: Health, International, Research; Faculty of Health Sciences, Faculty of Health Sciences, Bristol Medical School, Faculty of Health Sciences, Population Health Sciences, Institutes, Institutes, ALSPAC; Press Release Source Type: news

AI Metrics partners with UK-based company
AI Metrics, LLC, a Birmingham startup based at Innovation Depot, is partnering with the United Kingdom-based IQ-AI Limited to distribute AI Metric ’s software globally. The financial terms of the deal were not disclosed.  The company’s platform, which conducts a virtual liver biopsy, intends to enable chronic liver disease (CLD) assessment using commonly acquired CT images. AI Metrics enlisted the services of Imaging Biometrics, ad IQ- AI subsidiary, to help complete the translation of their… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - January 15, 2020 Category: Pharmaceuticals Source Type: news

Obesity crisis blamed for a rise in fatty liver disease amongst young adults
(University of Bristol) One in five young people have fatty liver disease (steatosis), with one in 40 having already developed liver scarring (fibrosis), research published today has found. The study, published in The Lancet Gastroenterology& Hepatology, is the first to attempt to determine the prevalence of fatty liver disease and fibrosis in young healthy adults in the UK. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 15, 2020 Category: International Medicine & Public Health Source Type: news

U.S. Drinking Deaths Double in 2 Decades With Faster Rate for Women: Study
Deaths from boozing and bingeing more than doubled in the past two decades, as alcohol consumption per person rose 8%, with sharp increases in the rate for women and the middle-aged. Men were three-quarters of the total but fatalities for women rose at a faster rate: 85% versus 39% for males, according to 1999-2017 research by the National Institute on Alcohol Abuse and Alcoholism. Total U.S. alcohol deaths reached 72,558 in 2017 — up from 35,914 in 1999 — with almost a third tied to liver disease, according to the study. Over 18 years, the total was almost 1 million. “The report is a wakeup call to the ...
Source: TIME: Health - January 11, 2020 Category: Consumer Health News Authors: Steve Geimann / Bloomberg Tags: Uncategorized onetime public health Source Type: news

Alcohol - Fueled Deaths Doubled in U.S. Over Past 20 Years
Nearly half of alcohol - related deaths resulted from liver disease or overdoses (Source: The Doctors Lounge - Psychiatry)
Source: The Doctors Lounge - Psychiatry - January 10, 2020 Category: Psychiatry Tags: Family Medicine, Gastroenterology, Internal Medicine, Emergency Medicine, Psychiatry, Journal, Source Type: news

Curcumin: Prevent liver disease and reduce liver fat with this amazing natural plant compound
(Natural News) Fatty liver disease, also known as hepatic steatosis, is a life-threatening condition caused by an abnormal buildup of fat in the liver. While it is usually caused by excessive alcohol drinking, this disease can also stem from non-alcoholic means. This fat buildup could lead to inflammation in the liver, causing damage and creating... (Source: NaturalNews.com)
Source: NaturalNews.com - January 9, 2020 Category: Consumer Health News Source Type: news

Number of Americans killed by alcohol DOUBLED in less than two decades, study finds 
Between 1999 and 2017, the number of US deaths from alcohol poisoning, liver disease and accidents linked to booze surged by over 100%, with the sharpest rise among white women, the NIH found. (Source: the Mail online | Health)
Source: the Mail online | Health - January 8, 2020 Category: Consumer Health News Source Type: news

Medical News Today: TIPS procedure: Everything you need to know
A transjugular intrahepatic portosystemic shunt (TIPS) procedure can help treat portal vein hypertension and other complications of advanced liver disease. Learn more here. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - January 6, 2020 Category: Consumer Health News Tags: Liver Disease / Hepatitis Source Type: news

Drug developer dips on failed psoriasis trial
Shares of drug developer Durect Corp. shed nearly a third of their value Thursday after the Cupertino company said its headline drug failed a mid-stage clinical trial aimed at people with itchy, scaly psoriasis. Durect's drug, called DUR-928, has been closely watched not only because of of the psoriasis study but because it also is being tested as a treatment for alcoholic hepatitis and nonalcoholic steatohepatitis, or NASH — a fatty liver disease that is one of the hottest potential commercial… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - January 2, 2020 Category: Pharmaceuticals Authors: Ron Leuty Source Type: news

Drug developer dips on failed psoriasis trial
Shares of drug developer Durect Corp. shed nearly a third of their value Thursday after the Cupertino company said its headline drug failed a mid-stage clinical trial aimed at people with itchy, scaly psoriasis. Durect's drug, called DUR-928, has been closely watched not only because of of the psoriasis study but because it also is being tested as a treatment for alcoholic hepatitis and nonalcoholic steatohepatitis, or NASH — a fatty liver disease that is one of the hottest potential commercial… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - January 2, 2020 Category: Biotechnology Authors: Ron Leuty Source Type: news

Supplementing with zinc reduces risk of liver cancer
(Natural News) Eating more foods rich in zinc may contribute to better liver health, a recent study finds. Researchers from the Osaka-Rosai Hospital in Japan found that zinc supplementation may help reduce the risk of liver cancer and other liver diseases. Through a controlled clinical trial, their findings revealed that patients with chronic liver disease... (Source: NaturalNews.com)
Source: NaturalNews.com - December 30, 2019 Category: Consumer Health News Source Type: news

5 Liver-Saving Strategies for the New Year 5 Liver-Saving Strategies for the New Year
Although the holidays can wreak havoc on the liver, patients can use simple interventions to modify their risk for the most common life-threatening liver diseases. Here's how.Medscape Gastroenterology (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - December 23, 2019 Category: Gastroenterology Tags: Gastroenterology Article Source Type: news

Medical News Today: Liver function tests: What to know
Liver function tests can help doctors determine whether a person has liver damage and what might be causing it. Learn about the tests and what the results mean here. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - December 21, 2019 Category: Consumer Health News Tags: Liver Disease / Hepatitis Source Type: news

Longevity protein SIRT6 also protects against fatty liver and fatty liver disease
(Bar-Ilan University) SIRT6 regulates fat metabolism by activating another protein called peroxisome proliferator-activated receptor alpha (PPAR-alpha). 'SIRT6 is like a juggler that coordinates between metabolic processes in the body,' says the study's lead author Prof. Haim Cohen. 'By working together with PPAR-alpha, SIRT6 can actually send a message to the body to burn more fat. This cooperation is one way in which SIRT6 protects against fatty liver and fatty liver disease, as well as obesity-related damage.' (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 20, 2019 Category: International Medicine & Public Health Source Type: news

5 Liver-Saving Strategies for the Holiday Season 5 Liver-Saving Strategies for the Holiday Season
Although the holidays can wreak havoc on the liver, patients can use simple interventions to modify their risk for the most common life-threatening liver diseases. Here's how.Medscape Gastroenterology (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - December 18, 2019 Category: Gastroenterology Tags: Gastroenterology Article Source Type: news

Peninsula company stock soars as it plots approval of rare liver disease drug
Mirum Pharmaceuticals will start filing paperwork in third-quarter 2020 for FDA approval of its drug in children with Alagille syndrome. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - December 16, 2019 Category: Biotechnology Authors: Ron Leuty Source Type: news

Peninsula company stock soars as it plots approval of rare liver disease drug
Mirum Pharmaceuticals will start filing paperwork in third-quarter 2020 for FDA approval of its drug in children with Alagille syndrome. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - December 16, 2019 Category: Pharmaceuticals Authors: Ron Leuty Source Type: news

Gilead's NASH combination treatment fails mid-stage study
Gilead Sciences Inc said on Monday all combinations of its three drugs to treat NASH were unsuccessful in a mid-stage study, the latest failure in a string of trials seeking to develop the first approved treatment for the fatty liver disease. (Source: Reuters: Health)
Source: Reuters: Health - December 16, 2019 Category: Consumer Health News Tags: healthNews Source Type: news

Autoimmune liver disease shock diagnosis for active woman aged 50
Esther Davidson, a now-retired special needs teacher from Edinburgh, was told she had the autoimmune liver disease primary biliary cholangitis following a routine blood donation. (Source: the Mail online | Health)
Source: the Mail online | Health - December 14, 2019 Category: Consumer Health News Source Type: news

Madrigal Pharmaceuticals investor selling large chunk of its stake
Investment funds affiliated with San Francisco-based Bay City Capital are selling about a quarter of their stake in Madrigal Pharmaceuticals, a West Conshohocken biopharmaceutical company developing treatment for cardiovascular, metabolic, and liver diseases. The investment funds, according to federal documents, expect to make $129.4 million by selling 1.2 million shares of Madrigal common stock at $107.85 per share. The secondary offering is set to close Dec. 13. The Bay City Capital affiliates… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - December 13, 2019 Category: Biotechnology Authors: John George Source Type: news

Medical News Today: What to know about false positives in hepatitis C testing
Blood tests can usually show whether a person has hepatitis C. However, these tests can give false-positive readings. Here, learn why this can happen. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - December 12, 2019 Category: Consumer Health News Tags: Liver Disease / Hepatitis Source Type: news

Walk your way to better health: Regular physical activity linked to lower risk of cirrhosis-related death
(Natural News) It cannot be stressed enough that physical activity, such as walking and working out, is vital for improving overall health. Now, a recent study suggests that physical activity can significantly benefit people suffering from liver disease. The study, presented at Digestive Disease Week 2019, found that physical activity was linked to a significant reduction in the... (Source: NaturalNews.com)
Source: NaturalNews.com - December 12, 2019 Category: Consumer Health News Source Type: news

Researchers look at the ability of cordyceps to "burn" fat in the liver
(Natural News) Extracts from the medicinal mushroom Cordyceps militaris can potentially be used to prevent — even reverse — nonalcoholic fatty liver disease (NAFLD), one of the most prevalent forms of liver disease among American adults. In a study published in the Journal of Medicinal Food, researchers from South Korea investigated whether C. militaris can regulate lipogenesis in the... (Source: NaturalNews.com)
Source: NaturalNews.com - December 12, 2019 Category: Consumer Health News Source Type: news

Exercise Impact on Physical Frailty in Chronic Liver Disease Exercise Impact on Physical Frailty in Chronic Liver Disease
A new review examines the therapeutic benefits of exercise in chronic liver disease. Could it help improve frailty and quality of life among these patients?Alimentary Pharmacology & Therapeutics (Source: Medscape Transplantation Headlines)
Source: Medscape Transplantation Headlines - December 11, 2019 Category: Transplant Surgery Tags: Gastroenterology Journal Article Source Type: news

Diet, not exercise, may be key to addressing our biggest cause of liver disease
(Edith Cowan University) Edith Cowan University researchers have found that a chronic disease affecting up to 80 per cent of overweight people may be causing an iron deficiency that simply leaves them too tired to get off the couch. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 11, 2019 Category: International Medicine & Public Health Source Type: news

Medical News Today: What is the prognosis for hepatitis C?
Hepatitis C (HCV) is a viral infection. Prognosis tends to depend on how soon a person receives a diagnosis and whether or not complications develop. Learn more about life expectancy with HCV here. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - December 5, 2019 Category: Consumer Health News Tags: Liver Disease / Hepatitis Source Type: news

Taming chronic inflammation may reduce illness, save lives
Scientists from 22 institutions, including UCLA, are recommending early diagnosis, prevention and treatment of severe chronic inflammation to reduce the risk of chronic disease and death worldwide.The group of international experts, which also includes scientists from the National Institutes of Health, Stanford University, Harvard Medical School, Columbia University Medical Center and University College London, point to inflammation-related diseases as the cause of 50 percent of all deaths worldwide.Inflammation is a naturally occurring response by the body ’s immune system that helps fight illness and infection. Whe...
Source: UCLA Newsroom: Health Sciences - December 5, 2019 Category: Universities & Medical Training Source Type: news

First investigational drug therapy for liver disease NASH awaiting FDA approval
Patients with nonalcoholic steatohepatitis (NASH), a chronic liver disease and a leading cause for liver transplantation in the U.S., currently lack an approved drug therapy, but this may soon change. A large Phase III clinical trial designed in collaboration with Virginia Commonwealth University is the first to demonstrate the safety and effectiveness of an oral medication to treat the disease. (Source: World Pharma News)
Source: World Pharma News - December 5, 2019 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news

First investigational drug therapy for liver disease NASH awaiting FDA approval
(Virginia Commonwealth University) Patients with nonalcoholic steatohepatitis (NASH), a chronic liver disease and a leading cause for liver transplantation in the US, currently lack an approved drug therapy, but this may soon change. A large Phase III clinical trial designed in collaboration with Virginia Commonwealth University is the first to demonstrate the safety and effectiveness of an oral medication to treat the disease. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 5, 2019 Category: International Medicine & Public Health Source Type: news

Zydus Cadila files NDA for Saroglitazar Magnesium
NASH is a progressive disease of the liver and a significant unmet medical need. There are currently no treatments available for the treatment of NASH. aroglitazar Mg has previously demonstrated improvement in both liver enzymes along with favorable effects on lipid and glycemic indices in patients with nonalcoholic fatty liver disease in Phase II clinical trials. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 5, 2019 Category: Pharmaceuticals Source Type: news

Modern TCM shows promise against liver cancer metastasis
(Natural News) Liver cancer is one of the deadliest types of human cancer. Hepatocellular carcinoma (HCC), which often occurs in patients with already existing liver disease, is considered the most common form of liver cancer. One of the main characteristics of HCC is its tendency to migrate or metastasize to the lungs. Metastasis of cancer... (Source: NaturalNews.com)
Source: NaturalNews.com - December 2, 2019 Category: Consumer Health News Source Type: news

Binge-drinking among millennials linked to skyrocketing rates of liver disease
(Natural News) The liver is one of the most resilient organs in your body, due to its unique ability to regenerate new and healthy tissue to replace damaged ones. This is important because the liver plays a major role in the body’s metabolic functions like breaking down substances and eliminating toxins from the body. Also, it even helps... (Source: NaturalNews.com)
Source: NaturalNews.com - November 30, 2019 Category: Consumer Health News Source Type: news

Drinking-related liver disease and deaths on the rise in U.S.
(Reuters Health) - Americans today are expected to live shorter lives than just a few years ago, in contrast with trends seen in other developed nations, and rising deaths from alcohol-related liver disease may be partly to blame, researchers say. (Source: Reuters: Health)
Source: Reuters: Health - November 29, 2019 Category: Consumer Health News Tags: healthNews Source Type: news

Targeting gut bacteria to treat alcoholic hepatitis
A therapy targeting bacteria that make a specific toxin lessened alcohol-associated liver disease in a mouse study. (Source: NIH Research Matters from the National Institutes of Health (NIH))
Source: NIH Research Matters from the National Institutes of Health (NIH) - November 26, 2019 Category: Consumer Health News Source Type: news